|
| |
 Dr. Nazarius Saah Lamango is an associate professor of medicinal chemistry in the College of Pharmacy and Pharmaceutical Sciences. Recently, he received a patent to treat cancers using compounds that block the activity of a unique enzyme. The activity of this enzyme is elevated in some tumors. Specifically, inhibiting the excess amounts of this enzyme would diminish its ability to process the target protein into the forms that promote tumor cell growth.
In 2002, Lamango received a patent (US patent number 6,372,793) regarding a method for treatment of a neurological disease characterized by an impaired neurological function. In 2006, it was licensed to Signum Bioscience, Inc.
Lamango has personally, or in collaboration with other faculty members, obtained more than $2 million in extramural research funding. His contributions in research have resulted in 30 publications in peer-reviewed journals and have been cited more than 700 times by fellow researchers.
He received his bachelor of science degree in agricultural chemistry and a PH.D. in biochemistry from the University of Leeds, United Kingdom. He also received a postdoctoral from Louisiana State University in New Orleans, La.
Lamango holds memberships with the American Society for Biochemistry and Molecular Biology and the America Association for the Advancement of Science.
|
|
|
